Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Data Unavailable

Employees

Website

www.mobergpharma.se

IPO Date

2011-05-26

Headquarters

Gustavslundsvägen 42, 5th floor, Bromma, Stockholm County, 167 51, Sweden

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Moberg Pharma MOB

Moberg Pharma Earnings Call Summary

Moberg Pharma Earnings

Transcripts

Events

About Moberg Pharma AB (publ)

Moberg Pharma
MOB